Q3 show boosts Nicholas Piramal

DALAL STREET SPIKES

Nicholas Piramal rose over 4.3 per cent to close at Rs 272.6 and was among the 10 best performers in the A group as robust Q3 results powered market sentiments.

The company's net profit increased 82 per cent to Rs 43 crore year-on-year even as topline growth was subdued at 14 per cent.

The good financial performance reinforces Nicholas's status as a key player in the formulations, diagnostics and vitamins segment of the domestic pharmaceutical industry besides a presence in exports markets. The stock has been fluctuating in the Rs 240-263 range since the beginning of this year.